Topiroxostat

Topiroxostat
Clinical data
Trade names	Topiloric, Uriadec
ATC code	None;
Legal status
Legal status	Approved in Japan;
Identifiers
	IUPAC name 4-[5-(4-Pyridinyl)-1H-1,2,4-triazol-3-yl]-2-pyridinecarbonitrile;
CAS Number	577778-58-6;
PubChem CID	5288320;
ChemSpider	4450517;
UNII	0J877412JV;
CompTox Dashboard (EPA)	DTXSID80206462 ;
Chemical and physical data
Formula	C13H8N6
Molar mass	248.249 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N;
	InChI InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19); Key:UBVZQGOVTLIHLH-UHFFFAOYSA-N;

Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia. It was approved for use in Japan in June 2013.

Topiroxostat is a xanthine oxidase inhibitor which reduces serum urate levels.